Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

New compounds may soon be tested to treat excessive hair growth in women.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Many patients on new leukemia drugs had mild to moderate skin reactions.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Finasteride and dutasteride can cause sexual problems like impotence and low libido.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

The method effectively measures drug impact on DHT levels in prostate treatments.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.